
PhD Candidate @Columbia University Irving Medical Center interested in hacking bacteria to deliver immunotherapy for cancer treatment.
New York, New Yok
Joined February 2019
- Tweets149
- Following624
- Followers111
- Likes156
Fangda Li retweeted
Thrilled to share the primary focus of my PhD thesis work, now out in @ScienceMagazine today!
We developed Trikines — engineered cytokines that reconfigure receptor complex assembly to reshape signaling directly in endogenous immune cells.
doi.org/10.1126/science.adx9…
Fangda Li retweeted
New publication out today in @natBME 🎉led by @zsinger JPabon demonstrating engineered bacteria launch and control a virus. A very cool cooperative microbial strategy for cancer therapy. Congrats to all! in collab with @RiceLaboratory
nature.com/articles/s41551-0…
Fangda Li retweeted
TGF-β and IL-12 conversely orchestrate formation of CD103+ CD8 tumor-resident memory T cells to regulate response to therapeutic cancer vaccine
cell.com/iscience/fulltext/S…
Fangda Li retweeted
Review: Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives
molecular-cancer.biomedcentr…
Fangda Li retweeted
Leveraging #SyntheticBiology techniques, researchers have engineered a strain of #Salmonella that can stimulate mature tertiary lymphoid structures to augment antitumor immunity and shrink #ColorectalCancer tumors in mice. scim.ag/4jZrDFg
Fangda Li retweeted
We previously showed that IFNg is required for CAR-T efficacy in solid tumors, but is it always good? Here, we show that IFNg limits CD28 CAR-T cells and that protection from this signal drives greater antitumor activity and durability. Enjoy!
science.org/doi/10.1126/scit…
Fangda Li retweeted
🚨 New Preprint 🚨
A continuous landscape of signaling encodes a corresponding landscape of CAR T cell phenotype
How can we tune JAK/STAT signaling to create better immune cell therapies?
doi.org/10.1101/2025.06.05.6…
Fangda Li retweeted
Excited to share a preprint of our latest study in collaboration w/ @tdanino's lab – synthetically engineered E. coli expressing CXCL13 synergizes with PD-1 blockade to amplify antitumor antibody responses and inhibit bladder cancer growth. @Columbia_MI biorxiv.org/content/10.1101/…
Excited to share my first author paper from my Ph.D.! I'd like to thank everyone in the Arpaia and Danino labs for their super human support!
Congrats @li_fangda and team! Another great collab w/ @tdanino's lab out today in @SciImmunology! Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms. @Columbia_MI @ColumbiaCMBS @columbiacancer science.org/doi/10.1126/scii…
10
173
Fangda Li retweeted
New paper in collab w/ @tdanino lab out today in @Nature! @andrewredenti, @JongwonIm8158 and team engineer probiotic E. coli as cancer vaccines to stimulate tumor neoantigen–specific immunity and kill solid tumors! @Columbia_MI @ColumbiaBME @columbiacancer nature.com/articles/s41586-0…
Fangda Li retweeted
New paper in collaboration w/@arpaialab out in Nature today! @andrewredenti, @JongwonIm8158 and team engineer E. coli Nissle probiotic as cancer vaccines nature.com/articles/s41586-0… @ColumbiaBME @columbiacancer. Congrats all!!
Fangda Li retweeted
Can table salt supercharge your immune system to fight cancer? According to research from CRI Lloyd J. Old STAR Dr. Enrico Lugli @luglilab, NaCl, or table salt, helps promote anti-cancer activity by preventing T cell exhaustion. Explore: bit.ly/3yWSAIk #CancerResearch
Fangda Li retweeted
Very happy to share this new work on LAG3 and PD1. Has been a long road to (begin to) sort out how LAG3 functions in CD8 T cell exhaustion. Great work by Shin Ngiow and super collaboration (and 2 other great papers) with @Vignali_Lab and Dario Vignali cell.com/cell/abstract/S0092…
Fangda Li retweeted
Bacteria in metastatic sites: Unveiling hidden players in cancer progression dlvr.it/T9Vrt5
Fangda Li retweeted
Efficacy of cancer immunotherapies depends upon the formation of intratumoral immune triads between antigen-presenting cells and antigen-specific CD4+ and CD8+ T cells @Cancer_Cell PREVIEQW by @luglilab cell.com/cancer-cell/abstrac…
Fangda Li retweeted
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors dlvr.it/T9L8n3
Fangda Li retweeted
New @ScienceMagazine publication from @KalluriLab @MDAndersonNews
Type I conventional dendritic cells facilitate immunotherapy in #PancreaticCancer
science.org/doi/10.1126/scie…
How is the tumor immune microenvironment of pancreatic cancer associated with pancreatitis (ptPDAC) different from cancer without preexisting pancreatitis (PDAC)?
De novo inflammation facilitates the recruitment of type 1 conventional dendritic cells (cDC1s), which attenuate T cell infiltration by inducing tolerance to self antigens and preventing tissue damage. In ptPDAC, cDC1s are activated & induce tolerogenic CD4 T cell infiltration that promotes tumor progression. The cDC1 phenotype of ptPDAC can be co-opted by exogenous administration of DC vaccines, promoting response to immune checkpoint inhibitor therapy.
This study highlights the importance of leveraging aspects of tumor promoting inflammation into a potential therapeutic modality.
Fangda Li retweeted
Our new paper on “synpoptosis” circuits, led by the amazing @ShiyuXia, is now out: sciencedirect.com/science/ar… (1/3)
Fangda Li retweeted
OK, this one is really meaningful for our whole team. Our preclinical paper on pan-RAS inhibition in pancreatic cancer is now online @Nature. Led by OliveLab student @ulawasko and Revolution Medicines colleagues JingJing Jiang and Mallika Singh. nature.com/articles/s41586-0…
Fangda Li retweeted
Heart felt thanks to Jian, Suxin, Maggie and all the coauthors for persevering through a comprehensive study elucidating the importance of STING-cDC1 in antitumor immunity. Grateful to support from @IOTNmoonshot and @CPRITTexas
scim.ag/5TL























